PTC Therapeutics to Participate at Upcoming Virtual Investor Conference

Rhea-AI Summary

PTC Therapeutics will present a company overview at the Credit Suisse 30th Annual Healthcare Conference on Nov. 9, 2021, at 8:00 a.m. ET. The presentation will be accessible via a live webcast on the company's investor site and archived for 30 days post-event. PTC focuses on developing innovative treatments for rare disorders, emphasizing a strong scientific foundation and global commercial capabilities to meet unmet patient needs.

SOUTH PLAINFIELD, N.J., Oct. 26, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, Nov. 9 at 8:00 a.m. ET.

The presentation will be webcast live on the Events and Presentations page on the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

 

View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-virtual-investor-conference-301406059.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics present at the Credit Suisse Healthcare Conference?

PTC Therapeutics will present on Nov. 9, 2021, at 8:00 a.m. ET.

How can I access the PTC Therapeutics presentation?

The presentation can be accessed via a live webcast on PTC Therapeutics' investor website.

What is the focus of PTC Therapeutics?

PTC Therapeutics is focused on discovering, developing, and commercializing medicines for rare disorders.

Where can I find more information about PTC Therapeutics?

More information about PTC Therapeutics can be found on their website at www.ptcbio.com.

Is the PTC presentation available after the event?

Yes, the presentation will be archived for 30 days following the event.